These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 35784334)

  • 1. Identification of Genes Related to 5-Fluorouracil Based Chemotherapy for Colorectal Cancer.
    Huang X; Ke K; Jin W; Zhu Q; Zhu Q; Mei R; Zhang R; Yu S; Shou L; Sun X; Feng J; Duan T; Mou Y; Xie T; Wu Q; Sui X
    Front Immunol; 2022; 13():887048. PubMed ID: 35784334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis reveals a novel 5-fluorouracil resistance-based prognostic signature with promising implications for predicting the efficacy of chemotherapy and immunotherapy in patients with colorectal cancer.
    Hou Y; Zhang F; Zong J; Li T; Gan W; Lv S; Yan Z; Zeng Z; Yang L; Zhou M; Zhao W; Yang M
    Apoptosis; 2024 Aug; 29(7-8):1126-1144. PubMed ID: 38824480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selumetinib overcomes ITGA2-induced 5-fluorouracil resistance in colorectal cancer.
    Qin J; Hu S; Lou J; Xu M; Gao R; Xiao Q; Chen Y; Ding M; Pan Y; Wang S
    Int Immunopharmacol; 2024 Aug; 137():112487. PubMed ID: 38889513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GOLPH3 predicts survival of colorectal cancer patients treated with 5-fluorouracil-based adjuvant chemotherapy.
    Wang Z; Jiang B; Chen L; Di J; Cui M; Liu M; Ma Y; Yang H; Xing J; Zhang C; Yao Z; Zhang N; Dong B; Ji J; Su X
    J Transl Med; 2014 Jan; 12():15. PubMed ID: 24444035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alarmin IL-33 orchestrates antitumoral T cell responses to enhance sensitivity to 5-fluorouracil in colorectal cancer.
    Song M; Yang J; Di M; Hong Y; Pan Q; Du Y; Xiang T; Liu J; Tang Y; Wang Q; Li Y; He J; Chen H; Zhao J; Weng D; Zhang Y; Xia JC
    Theranostics; 2023; 13(5):1649-1668. PubMed ID: 37056569
    [No Abstract]   [Full Text] [Related]  

  • 7. ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
    Dong S; Liang S; Cheng Z; Zhang X; Luo L; Li L; Zhang W; Li S; Xu Q; Zhong M; Zhu J; Zhang G; Hu S
    J Exp Clin Cancer Res; 2022 Jan; 41(1):15. PubMed ID: 34998404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the potential mechanisms of Yi-Yi-Fu-Zi-Bai-Jiang-San therapy on the immune-inflamed phenotype of colorectal cancer via combined network pharmacology and bioinformatics analyses.
    Liu Y; Liang Y; Su Y; Hu J; Sun J; Zheng M; Huang Z
    Comput Biol Med; 2023 Nov; 166():107432. PubMed ID: 37729701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a hypoxia-related gene prognostic signature in colorectal cancer based on bulk and single-cell RNA-seq.
    Qiao Y; Jiang X; Li Y; Wang K; Chen R; Liu J; Du Y; Sun L; Li J
    Sci Rep; 2023 Feb; 13(1):2503. PubMed ID: 36781976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer.
    Li C; Wirth U; Schardey J; Ehrlich-Treuenstätt VV; Bazhin AV; Werner J; Kühn F
    Front Immunol; 2023; 14():1156488. PubMed ID: 37483596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinacrine-Mediated Inhibition of Nrf2 Reverses Hypoxia-Induced 5-Fluorouracil Resistance in Colorectal Cancer.
    Kim HG; Kim CW; Lee DH; Lee JS; Oh ET; Park HJ
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiol oxidative stress-dependent degradation of transglutaminase2 via protein S-glutathionylation sensitizes 5-fluorouracil therapy in 5-fluorouracil-resistant colorectal cancer cells.
    Li X; Ma Y; Wu J; Ni M; Chen A; Zhou Y; Dai W; Chen Z; Jiang R; Ling Y; Yao Q; Chen W
    Drug Resist Updat; 2023 Mar; 67():100930. PubMed ID: 36736043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of sortilin is associated with 5-FU resistance and poor prognosis in colorectal cancer.
    Blondy S; Talbot H; Saada S; Christou N; Battu S; Pannequin J; Jauberteau MO; Lalloué F; Verdier M; Mathonnet M; Perraud A
    J Cell Mol Med; 2021 Jan; 25(1):47-60. PubMed ID: 33325631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
    Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
    Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Biomarker of Drug Resistance Developed From Patient-Derived Organoids Predicts Survival of Colorectal Cancer Patients.
    Chen L; Tian B; Liu W; Liang H; You Y; Liu W
    Front Oncol; 2022; 12():855674. PubMed ID: 35425715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The feedback loop of EFTUD2/c-MYC impedes chemotherapeutic efficacy by enhancing EFTUD2 transcription and stabilizing c-MYC protein in colorectal cancer.
    Zhu X; Li C; Gao Y; Zhang Q; Wang T; Zhou H; Bu F; Chen J; Mao X; He Y; Wu K; Li N; Luo H
    J Exp Clin Cancer Res; 2024 Jan; 43(1):7. PubMed ID: 38163859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-Aminobutyric Acid Type A Receptor Subunit Pi is a potential chemoresistance regulator in colorectal cancer.
    Wang T; Zhen Q; Wu T; Jin L; Yao S; Feng Y; Chen J; Chen C; Huang Z
    Mol Biol Rep; 2023 Apr; 50(4):3167-3177. PubMed ID: 36696022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long non-coding RNA HOTAIRM1 suppresses cell progression via sponging endogenous miR-17-5p/ B-cell translocation gene 3 (BTG3) axis in 5-fluorouracil resistant colorectal cancer cells.
    Ren T; Hou J; Liu C; Shan F; Xiong X; Qin A; Chen J; Ren W
    Biomed Pharmacother; 2019 Sep; 117():109171. PubMed ID: 31261026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syndecan-2, negatively regulated by miR-20b-5p, contributes to 5-fluorouracil resistance of colorectal cancer cells via the JNK/ERK signaling pathway.
    Hua R; Zhang Y; Yan X; Tang D; Li X; Ni Q; Wang D; Zhu J
    Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1547-1557. PubMed ID: 34596215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-139-5p sensitizes colorectal cancer cells to 5-fluorouracil by targeting NOTCH-1.
    Liu H; Yin Y; Hu Y; Feng Y; Bian Z; Yao S; Li M; You Q; Huang Z
    Pathol Res Pract; 2016 Jul; 212(7):643-9. PubMed ID: 27173050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.